opsonin pharma
TRANSCRIPT
Sabbir Ahmed142-11-3962
OVERVIEW Opsonin Pharma Ltd. (OPL) develops,
manufactures and markets generic medicines for human use.
MISSION
MARKET SHARE OF COMPANIES
Serial Pharma Tk (Crore) Market Share
Growth %
01 Square 1378 19.18 23.54
02 Incepta 650 9.05 32.17
03 Beximco 620 8.62 40.33
04 Opsonin 355 4.94 26.09
05 Eskayef 348 4.84 24.82
Hasan Sikder 142-11-3954
PRODUCTION FACIALITY:
Opsonin Pharma Ltd. operates on 350,000 square feet of manufacturing area.
4000 stakeholders. Opsonin Group employs more than 6000
people.
QUALITY ASSURANCE: Quality Assurance procedures ensure
that the quality of products are maintained.packaging materials and finished product.
Sharmin Afroz 142-11-3963
S.W.O.T• Well diversifies• Strong R & DStrength
• Insufficient working capital.
• Net operating in low cost market.
Weakness
Can add more products to its PFModern Technological advantages
Opportunity Fulfilling the
due commitments
Open market competition
Threat
Farida Hakim 142-11-3980
PESTEL ANALYSIS: Political Factors
Economic Factors
Environmental Factors
Legal Factors
Safia Akther 142-11-3774
PORTER’S 5 FORCE ANALYSIS:
Bargain Power Of Customer. Bargain Power of Supplier. Rivalry Among Existing Firms. Threat of Substitute Products. Threat of new Entrants.
Fahimul Haq 142-11-3968
PORTER’S 5 FORCE ANALYSIS
Buye
r
Supp
lier
Compe
tition
Subst
itute
New En
trants
0%40%80%
Very LowLowModerateHighVery High
Very High High Moderate Low Very LowBuyer 0 0 2 7 3
Supplier 0 2 2 5 3Competitor 1 5 3 2 1Substitute 0 0 3 4 5
New Entrant 6 3 2 1 0
A Small survey on 12 professional shows the following result
CONCLUSION:
The pharmaceutical industry is highly complex. The technologies leading to drug discovery and development are at the limits of human knowledge.